{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:17:07Z","timestamp":1788175027148,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"DOI":"10.1007\/s15010-026-02959-9","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:42:15Z","timestamp":1788172935000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical utility of time to positivity in candidemia: prognostic limitations and species-specific implications"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5814-5398","authenticated-orcid":false,"given":"Zehra Demirbas","family":"Yildiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8528-2163","authenticated-orcid":false,"given":"Mehmet","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Morkoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muge","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emin Ediz","family":"Tutuncu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"issue":"4","key":"2959_CR1","doi-asserted-by":"publisher","first-page":"S238","DOI":"10.1086\/598188","volume":"48","author":"H Seifert","year":"2009","unstructured":"Seifert H. The clinical importance of microbiological findings in the diagnosis and management of bloodstream infections. Clin Infect diseases: official publication Infect Dis Soc Am. 2009;48(4):S238\u201345. https:\/\/doi.org\/10.1086\/598188.","journal-title":"Clin Infect diseases: official publication Infect Dis Soc Am"},{"issue":"3","key":"2959_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1086\/421946","volume":"39","author":"H Wisplinghoff","year":"2004","unstructured":"Wisplinghoff H, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect diseases: official publication Infect Dis Soc Am vol. 2004;39(3):309\u201317. https:\/\/doi.org\/10.1086\/421946.","journal-title":"Clin Infect diseases: official publication Infect Dis Soc Am vol"},{"issue":"4","key":"2959_CR3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cmi.2015.01.003","volume":"21","author":"O Opota","year":"2015","unstructured":"Opota O, et al. Blood culture-based diagnosis of bacteraemia: state of the art. Clin Microbiol infection: official publication Eur Soc Clin Microbiol Infect Dis vol. 2015;21(4):313\u201322. https:\/\/doi.org\/10.1016\/j.cmi.2015.01.003.","journal-title":"Clin Microbiol infection: official publication Eur Soc Clin Microbiol Infect Dis vol"},{"key":"2959_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00697","author":"B Lamy","year":"2016","unstructured":"Lamy B, et al. How to optimize the use of blood cultures for the diagnosis of bloodstream infections? A state-of-the art. Front Microbiol. 2016. https:\/\/doi.org\/10.3389\/fmicb.2016.00697","journal-title":"Front Microbiol"},{"key":"2959_CR5","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.eimc.2016.10.003","volume":"35","author":"G Mart\u00edn-Guti\u00e9rrez","year":"2017","unstructured":"Mart\u00edn-Guti\u00e9rrez G, et al. Time to positivity of blood cultures in patients with bloodstream infections: A useful prognostic tool. Enfermedades infecciosas y Microbiol Clin vol. 2017;35:638\u201344. https:\/\/doi.org\/10.1016\/j.eimc.2016.10.003.","journal-title":"Enfermedades infecciosas y Microbiol Clin vol"},{"key":"2959_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jgar.2022.06.026","volume":"30","author":"M Rolo","year":"2022","unstructured":"Rolo M, et al. Clinical impact of time-to-positivity of blood cultures on mortality in patients with Pseudomonas aeruginosa bacteremia. J global Antimicrob Resist. 2022;30:269\u201375. https:\/\/doi.org\/10.1016\/j.jgar.2022.06.026.","journal-title":"J global Antimicrob Resist"},{"issue":"7","key":"2959_CR7","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.cmi.2024.03.032","volume":"30","author":"KB Laupland","year":"2024","unstructured":"Laupland KB, et al. Time to positivity is a risk factor for death among patients with bloodstream infections: a population-based cohort. Clin Microbiol infection: official publication Eur Soc Clin Microbiol Infect Dis vol. 2024;30(7):899\u2013904. https:\/\/doi.org\/10.1016\/j.cmi.2024.03.032.","journal-title":"Clin Microbiol infection: official publication Eur Soc Clin Microbiol Infect Dis vol"},{"issue":"1","key":"2959_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.37201\/req\/094.2024","volume":"38","author":"P Maffezzoli","year":"2025","unstructured":"Maffezzoli P, et al. Diagnostic and prognostic value of time to positivity in blood cultures. An opinion paper. Revista Esp de quimioterapia: publicacion oficial de la Sociedad Esp de Quimioterapia. 2025;38(1):8\u201320. https:\/\/doi.org\/10.37201\/req\/094.2024.","journal-title":"Revista Esp de quimioterapia: publicacion oficial de la Sociedad Esp de Quimioterapia"},{"key":"2959_CR9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.66364","author":"L Balaji","year":"2024","unstructured":"Balaji L, et al. Time-to-positivity for candida in bloodstream infections: prognostic implications for mortality. Cureus. 2024. https:\/\/doi.org\/10.7759\/cureus.66364","journal-title":"Cureus"},{"issue":"12","key":"2959_CR10","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1093\/jac\/dkt256","volume":"68","author":"Si Kim","year":"2013","unstructured":"Kim Si-(, et al. Clinical impact of time to positivity for Candida species on mortality in patients with candidaemia. J Antimicrob Chemother vol. 2013;68(12):2890\u20137. https:\/\/doi.org\/10.1093\/jac\/dkt256.","journal-title":"J Antimicrob Chemother vol"},{"issue":"4","key":"2959_CR11","doi-asserted-by":"publisher","first-page":"myad028","DOI":"10.1093\/mmy\/myad028","volume":"61","author":"C Keighley","year":"2023","unstructured":"Keighley C, et al. Time-to-positivity in bloodstream infection for Candida species as a prognostic marker for mortality. Med Mycol vol. 2023;61(4):myad028. https:\/\/doi.org\/10.1093\/mmy\/myad028.","journal-title":"Med Mycol vol"},{"key":"2959_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-486","author":"CZ Nunes","year":"2013","unstructured":"Nunes CZ, et al. Time to blood culture positivity as a predictor of clinical outcome in patients with Candida albicans bloodstream infection. BMC Infect Dis. 2013. https:\/\/doi.org\/10.1186\/1471-2334-13-486","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2959_CR13","doi-asserted-by":"publisher","first-page":"136e7","DOI":"10.1016\/j.cmi.2021.05.043","volume":"28","author":"F Hamilton","year":"2022","unstructured":"Hamilton F, et al. Time to positivity in bloodstream infection is not a prognostic marker for mortality: analysis of a prospective multicentre randomized control trial. Clin Microbiol infection: official publication Eur Soc Clin Microbiol Infect Dis vol. 2022;28(1):136e7. 136.e13.","journal-title":"Clin Microbiol infection: official publication Eur Soc Clin Microbiol Infect Dis vol"},{"issue":"2","key":"2959_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.18502\/ijm.v16i2.15361","volume":"16","author":"A Sachu","year":"2024","unstructured":"Sachu A, et al. Time to positivity of blood cultures causing candidemia and its relation to mortality. Iran J Microbiol vol. 2024;16(2):263\u201372. https:\/\/doi.org\/10.18502\/ijm.v16i2.15361.","journal-title":"Iran J Microbiol vol"},{"key":"2959_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ijmmb.2022.08.014","volume":"43","author":"H Kaur","year":"2023","unstructured":"Kaur H, et al. Clinical utility of time to positivity of blood cultures in cases of fungaemia: A prospective study. Ind J Med Microbiol. 2023;43:85\u20139. https:\/\/doi.org\/10.1016\/j.ijmmb.2022.08.014.","journal-title":"Ind J Med Microbiol"},{"key":"2959_CR16","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S383846","author":"X Yang","year":"2022","unstructured":"Yang X, et al. Time to positivity facilitates an early differential diagnosis of candida tropicalis from other candida species. Infect drug Resist. 2022. https:\/\/doi.org\/10.2147\/IDR.S383846","journal-title":"Infect drug Resist"},{"key":"2959_CR17","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1099\/jmm.0.038166-0","volume":"61","author":"C-C Lai","year":"2012","unstructured":"Lai C-C, et al. Time to positivity of blood cultures of different Candida species causing fungaemia. J Med Microbiol vol. 2012;61:701\u20134. https:\/\/doi.org\/10.1099\/jmm.0.038166-0.","journal-title":"J Med Microbiol vol"},{"key":"2959_CR18","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1016\/S1473-3099(24)00749-7","volume":"25","author":"OA Cornely","year":"2025","unstructured":"Cornely OA, et al. Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM. Lancet Infect Dis vol. 2025;25:e280\u201393. https:\/\/doi.org\/10.1016\/S1473-3099(24)00749-7.","journal-title":"Lancet Infect Dis vol"},{"issue":"4","key":"2959_CR19","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","volume":"62","author":"G Pappas, Peter","year":"2016","unstructured":"Pappas, Peter G, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect diseases: official publication Infect Dis Soc Am vol. 2016;62(4):e1\u201350. https:\/\/doi.org\/10.1093\/cid\/civ933.","journal-title":"Clin Infect diseases: official publication Infect Dis Soc Am vol"},{"key":"2959_CR20","unstructured":"Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O\u2019Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1\u201345. doi: 10.1086\/599376 Erratum in: Clin Infect Dis. 2010;50(7):1079. Dosage error in article text. Erratum in: Clin Infect Dis. 2010;50(3):457. PMID: 19489710; PMCID: PMC4039170."}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02959-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-026-02959-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02959-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:42:17Z","timestamp":1788172937000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-026-02959-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":20,"alternative-id":["2959"],"URL":"https:\/\/doi.org\/10.1007\/s15010-026-02959-9","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data were extracted retrospectively from the patient\u2019s electronic health records and were de-identified to protect patient\u2019s confidentiality. Ethical approval of the study and a waiver of patient\u2019s informed consent was provided by the Ethics Committee of Ankara Etlik City Hospital (14.08.2024, 2024\u2212732). This study was performed in accordance with the Declaration of Helsinki and relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}